{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T21:36:07Z","timestamp":1649194567332},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,6,15]]},"DOI":"10.2169\/internalmedicine.4259-19","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T22:05:32Z","timestamp":1584569132000},"page":"1531-1533","source":"Crossref","is-referenced-by-count":0,"title":["A Young Patient Presenting with Atrioventricular Block Diagnosed as Myotonic Dystrophy"],"prefix":"10.2169","volume":"59","author":[{"given":"Hiroshi","family":"Onoda","sequence":"first","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"},{"name":"Division of Cardiology, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruhiko","family":"Imamura","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Ushijima","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"Sobajima","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Kinugawa","sequence":"additional","affiliation":[{"name":"The Second Department of Internal Medicine, University of Toyama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mathieu J, Allard P, Potvin L, Prevost C, Begin P. A 10-year study of mortality in a cohort of patients with myotonic dystrophy. Neurology 52: 1658-1662, 1999.","DOI":"10.1212\/WNL.52.8.1658"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Pelargonio G, Dello Russo A, Sanna T, De Martino G, Bellocci F. Myotonic dystrophy and the heart. Heart 88: 665-670, 2002.","DOI":"10.1136\/heart.88.6.665"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Petri H, Vissing J, Witting N, Bundgaard H, Kober L. Cardiac manifestations of myotonic dystrophy type 1. Int J Cardiol 160: 82-88, 2012.","DOI":"10.1016\/j.ijcard.2011.08.037"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Rakocevic Stojanovic V, Peric S, Paunic T, et al. Cardiologic predictors of sudden death in patients with myotonic dystrophy type 1. J Clin Neurosci 20: 1002-1006, 2013.","DOI":"10.1016\/j.jocn.2012.09.014"},{"key":"5","unstructured":"5. Lazarus A, Varin J, Babuty D, Anselme F, Coste J, Duboc D. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol 40: 1645-1652, 2002."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Groh WJ, Groh MR, Saha C, et al. Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1. N Engl J Medi 358: 2688-2697, 2008.","DOI":"10.1056\/NEJMoa062800"},{"key":"7","unstructured":"7. Lau JK, Sy RW, Corbett A, Kritharides L. Myotonic dystrophy and the heart: a systematic review of evaluation and management. Int J Cardiol 184: 600-608, 2015."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Bhakta D, Shen C, Kron J, Epstein AE, Pascuzzi RM, Groh WJ. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population. J Cardiovasc Electrophysiol 22: 1369-1375, 2011.","DOI":"10.1111\/j.1540-8167.2011.02200.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wahbi K, Babuty D, Probst V, et al. Incidence and predictors of sudden death, major conduction defects and sustained ventricular tachyarrhythmias in 1388 patients with myotonic dystrophy type 1. Eur Heart J 38: 751-758, 2017.","DOI":"10.1093\/eurheartj\/ehw569"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nakamori M, Gourdon G, Thornton CA. Stabilization of expanded (CTG) * (CAG) repeats by antisense oligonucleotides. Mol Ther 19: 2222-2227, 2011.","DOI":"10.1038\/mt.2011.191"},{"key":"11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11362","volume":"488","author":"TM Wheeler","year":"2012","unstructured":"11. Wheeler TM, Leger AJ, Pandey SK, et al. Targeting nuclear RNA for <i>in vivo<\/i> correction of myotonic dystrophy. Nature 488: 111-115, 2012.","journal-title":"?Nature","ISSN":"http:\/\/id.crossref.org\/issn\/0028-0836","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/12\/59_4259-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T03:30:10Z","timestamp":1592623810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/12\/59_4259-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,15]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.4259-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,15]]}}}